RAGE and TLRs as Key Targets for Antiatherosclerotic Therapy - PubMed (original) (raw)

Review

. 2018 Aug 26:2018:7675286.

doi: 10.1155/2018/7675286. eCollection 2018.

Affiliations

Review

RAGE and TLRs as Key Targets for Antiatherosclerotic Therapy

Wioletta Olejarz et al. Biomed Res Int. 2018.

Abstract

Receptor for advanced glycation end-products (RAGE) and toll-like receptors (TLRs) are the key factors indicating a danger to the organism. They recognize the microbial origin pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs). The primary response induced by PAMPs or DAMPs is inflammation. Excessive stimulation of the innate immune system occurs in arterial wall with the participation of effector cells. Persistent adaptive responses can also cause tissue damage and disease. However, inflammation mediated by the molecules innate responses is an important way in which the adaptive immune system protects us from infection. The specific detection of PAMPs and DAMPs by host receptors drives a cascade of signaling that converges at nuclear factor-_κ_B (NF-_κ_B) and interferon regulatory factors (IRFs) and induces the secretion of proinflammatory cytokines, type I interferon (IFN), and chemokines, which promote direct killing of the pathogen. Therefore, signaling of these receptors' pathways also appear to present new avenue for the modulation of inflammatory responses and to serve as potential novel therapeutic targets for antiatherosclerotic therapy.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Stimulation of RAGE and TLRs leads to the activation of the transcription nuclear factor NF-_κ_B. Transfer of NF-_κ_B to the nucleus induces inflammatory response and leukocyte recruitment. AGE: advanced glycation end-products, HMGB1: high-mobility group box 1 protein, Ox LDL: oxidized low-density lipoprotein, HSP: Heat shock proteins, and NF-_κ_B: nuclear factor _κ_B.

Figure 2

Figure 2

Toll-like receptor signaling pathways. IRFs: interferon regulatory factors, NF-_κ_B: nuclear factor κ_B, IRAK: IL-1 receptor-associated kinases; MAL: MyD88-adaptor-like; MyD88: Myeloid differentiation protein 88; TLR: toll-like receptor; TRAF: tumour necrosis factor receptor-associated factor 6; TRAM: TRIF-related adaptor molecule; TRIF: TIR domain-containing adaptor inducing interferon-β. I_κ_B_α : inhibitory protein kappa-B and IKK: inhibitor of nuclear factor kappa-B kinase.

References

    1. Witztum J. L., Lichtman A. H. The influence of innate and adaptive immune responses on atherosclerosis. Annual Review of Pathology: Mechanisms of Disease. 2014;9:73–102. doi: 10.1146/annurev-pathol-020712-163936. - DOI - PMC - PubMed
    1. Bangert A., Andrassy M., Müller A. M. Critical role of RAGE and HMGB1 in inflammatory heart disease. Proceedings of the National Acadamy of Sciences of the United States of America. 2016;113(2):E155–E164. doi: 10.1073/pnas.1522288113. - DOI - PMC - PubMed
    1. Cai Z. Role of RAGE in Alzheimer's Disease. Cell Mol Neurobiol. 2016;36(4):483–495. - PMC - PubMed
    1. Ramasamy R., Shekhtman A., Schmidt A. M. The multiple faces of RAGE-opportunities for therapeutic intervention in aging and chronic disease. Expert Opinion on Therapeutic Targets. 2016;20(4):431–446. doi: 10.1517/14728222.2016.1111873. - DOI - PMC - PubMed
    1. Xue J., Manigrasso M., Scalabrin M., et al. Change in the Molecular Dimension of a RAGE-Ligand Complex Triggers RAGE Signaling. Structure. 2016;24(9):1509–1522. doi: 10.1016/j.str.2016.06.021. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources